FERROUS SULFATE

Product NDC
24451-002
11-digit product format
244510002
Labeler code
24451
Product ID
24451-002_38d13c4f-3921-4676-827d-146202172021
Type
HUMAN OTC DRUG
Nonproprietary name
FERROUS SULFATE
Dosage form
ELIXIR
Route
ORAL
Labeler
LLC Federal Solutions
Marketing category
UNAPPROVED DRUG OTHER
Marketing start
2013-08-12
Marketing end
0000-00-00
Substance
FERROUS SULFATE
Active strength
220 mg/5mL
NDC exclude flag
E
Listing certified through
2017-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct24451-002DDiscontinued by firm2026-08-17
excluded packagepackage24451-00224451-002-05DDiscontinued by firm2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 26 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductDDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage24451-002-05DDiscontinued by firmd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductDDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage24451-002-05DDiscontinued by firmf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproductDDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage24451-002-05DDiscontinued by firm2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproductDDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage24451-002-05DDiscontinued by firma1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductDDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage24451-002-05DDiscontinued by firmcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductDDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage24451-002-05DDiscontinued by firmcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproductDDiscontinued by firm302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage24451-002-05DDiscontinued by firm302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproductDDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage24451-002-05DDiscontinued by firmed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproductDDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage24451-002-05DDiscontinued by firm0efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductDDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage24451-002-05DDiscontinued by firmad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproductDDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage24451-002-05DDiscontinued by firm367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproductDDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage24451-002-05DDiscontinued by firm557ba5c1ecfa…9c80585c8c6e…
2019-12-08 06:16 UTC · source 2019-12-05excluded productproductIInactivated by FDA110d247fa046…a55b01930146…
2019-12-08 06:16 UTC · source 2019-12-05excluded packagepackage24451-002-05IInactivated by FDA110d247fa046…a55b01930146…

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
24451-002-052020-01-07C16284748780-19855d018-dcac-cd31-e053-dbdaa90ab51ab836e241-e47c-405b-b1e0-7a93fc809a32
24451-002-052019-11-27C16284748780-19855d018-dcac-cd31-e053-dbdaa90ab51ab836e241-e47c-405b-b1e0-7a93fc809a32

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
FERROUS SULFATEACTIVE INGREDIENT39R4TAN1VTFERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
FERROUS CATIONACTIVE MOIETYGW89581OWRFERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
ALCOHOLINACTIVE INGREDIENT3K9958V90MFERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
ASCORBIC ACIDINACTIVE INGREDIENTPQ6CK8PD0RFERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
CITRIC ACID MONOHYDRATEINACTIVE INGREDIENT2968PHW8QPFERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8FERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3FERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
SACCHARIN SODIUMINACTIVE INGREDIENTSB8ZUX40TYFERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
SODIUM BENZOATEINACTIVE INGREDIENTOJ245FE5EUFERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
SORBITOLINACTIVE INGREDIENT506T60A25RFERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
SUCROSEINACTIVE INGREDIENTC151H8M554FERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3
WATERINACTIVE INGREDIENT059QF0KO0RFERROUS SULFATE ELIXIR [LLC FEDERAL SOLUTIONS]3